NCT01828879View on ClinicalTrials.gov

An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis

PHASE4CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2009

Conditions
Dermatitis, Atopic
Interventions
DRUG

Tacrolimus

Tacrolimus ointment, 0.1 percent will be applied twice daily, in adult population for 4 weeks or until 1 week after the affected areas defined for treatment at baseline are completely cleared, whichever is first.

Trial Locations (2)

Unknown

Hanoi

Hochiminh

All Listed Sponsors
lead

Janssen-Cilag Ltd.,Thailand

INDUSTRY

NCT01828879 - An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis | Biotech Hunter | Biotech Hunter